Sands Capital Ventures
ActiveFiled to raiseArlington, VABiotech & pharma, AI & machine learning, Manufacturing & industrialsLast fund filed 2026
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Sands Capital - EYN | February 2026 | Indefinite | $2M | 2 |
| Sands Capital Global Innovation Fund III-3 | February 2026 | Indefinite | $113M | 26 |
| Sands Capital - ISFiled to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Opportunities FundFiled to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
13 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Chris EngNot on the current fund | Selective | None listed | 2 |
Categories of Sands Capital Ventures’s own portfolio companies, based on 7 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Sands Capital Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| 82vs | 1 | Avitide |
| 9Yards Capital | 1 | GEORGIA BANKING CO |
| Accel | 1 | Mitra RxDx |
| Accel India | 1 |
| Sands Capital Global Venture Fund IV (DE)Filed to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund IV-ISFiled to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund IVFiled to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| SC-PM Fund 1Filed to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| SCH Diversifying Fund-IRFiled to raise in 2026, with no closing reported yet. | 2026 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund III-RP | April 2025 | Indefinite | $20M | 2 |
| Sands Capital Life Sciences Pulse Fund III | March 2025 | Indefinite | $8M | 1 |
| Sands Capital Scaling Innovation FundFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund III-XFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund III-2Filed to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund II-FGFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Sands Capital Horizons Public Equity Partners FundFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund III | 2025 | Indefinite | $973M | 280 |
| SCH Diversifying Fund-AFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund II-ANFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund II-PAFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund II-SLXFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund II-DBFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| Sands Capital Life Sciences Pulse Fund III (DE)Filed to raise in 2023, with no closing reported yet. | 2023 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund III-SFRFiled to raise in 2023, with no closing reported yet. | 2023 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund III | October 2021 | Indefinite | $202M | 93 |
| Sands Capital Global Venture Fund I-UPGFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Life Sciences Pulse Opportunities FundFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Life Sciences Pulse Fund IIFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund II-KLVFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund IIFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Global Venture Fund III-SBRFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund II-GSTFiled to raise in 2021, with no closing reported yet. | 2021 | Indefinite | $0 | 0 |
| Sands Capital Global Innovation Fund-SX | December 2020 | Indefinite | $15M | 40 |
| Sands Capital Global Innovation Fund-BYJUs | September 2020 | $44M | $44M | 57 |
| Sands Capital Global Innovation Fund-SMS | June 2020 | $7.6M | $7.6M | 23 |
| Sands Capital-DR Fund | September 2019 | Indefinite | $5.1M | 37 |
| Sands Capital Global Innovation Fund-UIP | September 2019 | Indefinite | $10M | 33 |
| Sands Capital Life Sciences Pulse Fund C-1 | June 2019 | Indefinite | $23M | 12 |
| Sands Capital Life Sciences Pulse Fund-GP | June 2019 | Indefinite | $1.1M | 18 |
| Sands Capital Life Sciences Pulse Fund | June 2019 | Indefinite | $91M | 22 |
| Sands Capital Global Innovation Fund-GP | June 2019 | Indefinite | $630,000 | 14 |
| Sands Capital Global Innovation Fund | June 2019 | Indefinite | $111M | 28 |
| Sands Capital Life Sciences Pulse Fund C-1-GP | June 2019 | $470,000 | $470,000 | 12 |
| Sands Capital Global Innovation Fund C-1-GP | June 2019 | Indefinite | $340,000 | 9 |
| Sands Capital Global Innovation Fund C-1 | June 2019 | Indefinite | $29M | 17 |
| Sands Capital Private Growth Fund III-DC | December 2018 | $5.1M | $5.1M | 22 |
| Sands Capital Ventures Fund-SLK | October 2018 | $4.5M | $4.5M | 42 |
| Sands Capital Private Growth Fund III | July 2018 | Indefinite | $122M | 55 |
| SANDS CAPITAL PRIVATE GROWTH FUND-HC3 | December 2017 | $933,517 | $933,517 | 7 |
| SANDS CAPITAL PRIVATE GROWTH FUND II-BLBK | December 2017 | $2.6M | $2.6M | 14 |
| SANDS CAPITAL PRIVATE GROWTH FUND II-UH | December 2017 | $5M | $5M | 10 |
| SANDS CAPITAL PRIVATE GROWTH BB FUND-2 | August 2017 | $2.1M | $2.1M | 6 |
| Sands Capital Private Growth BB Fund | December 2016 | $11M | $11M | 24 |
| Sands Capital Private Growth Fund-HC2 | June 2016 | $2.5M | $2.5M | 8 |
| Sands Capital Private Growth Fund II-MB | June 2016 | $5M | $5M | 16 |
| Sands Capital Private Growth Fund II | April 2016 | Indefinite | $90M | 50 |
| Sands Capital Private Growth Fund-MM | August 2015 | $7.5M | $6.1M | 19 |
| Sands Capital Private Growth Fund-SQ | July 2015 | Indefinite | $2.5M | 23 |
| Sands Capital Private Growth Fund-MS | July 2015 | Indefinite | $2.5M | 28 |
| Sands Capital Private Growth Fund-HC | May 2015 | $5M | $3.7M | 26 |
| Sands Capital Private Growth Fund-FC | May 2015 | $14M | $12M | 36 |
| Sands Capital Private Growth Fund | November 2014 | Indefinite | $77M | 42 |
| 2 |
| Jonathan Goodman | Slowing | Manufacturing & industrials | 6 | 1 |
| Scott FrederickNot on the current fund | Slowing | AI & machine learning | 4 | 1 |
| Barron MartinNot on the current fund | Quiet | None listed | 0 | 0 |
| Erin Soule | Quiet | None listed | 1 | 0 |
| Frank SandsNot on the current fund | Quiet | None listed | 0 | 0 |
| Ian RatcliffeNot on the current fund | Quiet | Biotech & pharma, Medical devices | 10 | 0 |
| Job TaylorNot on the current fund | Quiet | None listed | 0 | 0 |
| Joseph AndraskoNot on the current fund | Quiet | Medical devices | 3 | 0 |
| Marina SerenbetzNot on the current fund | Quiet | None listed | 0 | 0 |
| Michael ClarkeNot on the current fund | Quiet | None listed | 5 | 0 |
| Michael GraningerNot on the current fund | Quiet | None listed | 2 | 0 |
| Stephen ZacharyNot on the current fund | Quiet | Biotech & pharma | 3 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| Mitra RxDx |
| Borealis | 1 | Avitide |
| First Spark Ventures | 1 | VITARA BIOMEDICAL |
| Florida Funders | 1 | HealthSnap |
| Mischief | 1 | iVerify |
| MPM BioVentures | 1 | DiCE MOLECULES HOLDINGS |
| OCA Ventures | 1 | Automated Insights |
| Omega Funds | 1 | Avitide |
| SV Life Sciences | 1 | Avitide |
A shared board seat: a company where filings name a Sands Capital Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.